Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Missed Opportunities for Early Diabetes Screening in Pregnancy.

Battarbee AN, Cavallini M, Keller C, Boggess KA.

Am J Perinatol. 2019 Aug 17. doi: 10.1055/s-0039-1694727. [Epub ahead of print]

PMID:
31421638
2.

Intrapartum Group B Streptococcus Antibiotic Prophylaxis in Penicillin Allergic Pregnant Women.

Desravines N, Venkatesh KK, Hopkins A, Waldron J, Grant M, McGuire C, Boggess KA.

AJP Rep. 2019 Jul;9(3):e238-e243. doi: 10.1055/s-0039-1694031. Epub 2019 Jul 30.

3.

Risk factors associated with prolonged neonatal intensive care unit stay after threatened late preterm birth.

Battarbee AN, Glover AV, Vladutiu CJ, Gyamfi-Bannerman C, Aliaga S, Manuck TA, Boggess KA.

J Matern Fetal Neonatal Med. 2019 Jun 6:1-6. doi: 10.1080/14767058.2019.1623777. [Epub ahead of print]

PMID:
31170845
4.

Ubiquitous identification of inorganic arsenic in a cohort of second trimester amniotic fluid in women with preterm and term births.

Johnson J, Robinson S, Smeester L, Fry R, Boggess K, Vora N.

Reprod Toxicol. 2019 Aug;87:97-99. doi: 10.1016/j.reprotox.2019.05.061. Epub 2019 May 23. Review. No abstract available.

PMID:
31128209
5.

The development of a theory-based eHealth app prototype to promote oral health during prenatal care visits.

Vamos CA, Griner SB, Kirchharr C, Green SM, DeBate R, Daley EM, Quinonez RB, Boggess KA, Jacobs T, Christiansen S.

Transl Behav Med. 2019 Apr 22. pii: ibz047. doi: 10.1093/tbm/ibz047. [Epub ahead of print]

PMID:
31009536
6.

Sex-Specific Differences in Late Preterm Neonatal Outcomes.

Battarbee AN, Glover AV, Vladutiu CJ, Gyamfi-Bannerman C, Aliaga S, Manuck TA, Boggess KA.

Am J Perinatol. 2019 Apr 16. doi: 10.1055/s-0039-1683886. [Epub ahead of print]

PMID:
30991441
7.

Effect of a High-Fat Diet and Metformin on Placental mTOR Signaling in Mice.

Grace MR, Dotters-Katz SK, Zhou C, Manuck T, Boggess K, Bae-Jump V.

AJP Rep. 2019 Apr;9(2):e138-e143. doi: 10.1055/s-0039-1683362. Epub 2019 Apr 9.

8.

Incidence and Risk Factors for Hospital Readmission or Unexpected Visits in Women Undergoing Unscheduled Cesarean Delivery.

La Rosa M, Jauk V, Saade GR, Boggess K, Longo S, Clark EAS, Esplin S, Cleary K, Wapner R, Letson K, Owens MY, Blackwell S, Szychowski JM, Andrews W, Tita AT; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium.

Am J Perinatol. 2019 Mar 15. doi: 10.1055/s-0039-1683391. [Epub ahead of print]

PMID:
30877684
9.

RNA-Sequencing of Umbilical Cord Blood to Investigate Spontaneous Preterm Birth: A Pilot Study.

Vora NL, Parker JS, Mieckowski PA, Smeester L, Fry RC, Boggess KA.

AJP Rep. 2019 Jan;9(1):e60-e66. doi: 10.1055/s-0039-1678717. Epub 2019 Mar 7.

10.

Impact of Azithromycin-Based Extended-Spectrum Antibiotic Prophylaxis on Noninfectious Cesarean Wound Complications.

Ausbeck EB, Jauk VC, Boggess KA, Saade GR, Longo S, Clark EAS, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Abramovici A, Ambalavanan N, Szychowski JM, Andrews W, Tita ATN; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium.

Am J Perinatol. 2019 Jul;36(9):886-890. doi: 10.1055/s-0039-1679914. Epub 2019 Feb 19.

PMID:
30780190
11.

Management of diabetic women with threatened preterm birth: a survey of Maternal-Fetal Medicine providers.

Battarbee AN, Aliaga S, Boggess KA.

J Matern Fetal Neonatal Med. 2019 Jan 24:1-9. doi: 10.1080/14767058.2019.1566307. [Epub ahead of print]

PMID:
30678514
12.

Rationale, design, and methods for the Medical Optimization and Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD) study.

Berry DC, Thomas SD, Dorman KF, Ivins AR, de Los Angeles Abreu M, Young L, Boggess K.

BMC Pregnancy Childbirth. 2018 Dec 12;18(1):488. doi: 10.1186/s12884-018-2108-3.

13.

Association of Long-term Child Growth and Developmental Outcomes With Metformin vs Insulin Treatment for Gestational Diabetes.

Landi SN, Radke S, Engel SM, Boggess K, Stürmer T, Howe AS, Funk MJ.

JAMA Pediatr. 2019 Feb 1;173(2):160-168. doi: 10.1001/jamapediatrics.2018.4214. Erratum in: JAMA Pediatr. 2019 Feb 1;173(2):199.

PMID:
30508164
14.

Factors Associated with Previable Delivery following Second Trimester Rupture of Membranes.

Panzer A, Dotters-Katz S, Smid M, Boggess K, Manuck T.

Am J Perinatol. 2019 Jul;36(8):812-817. doi: 10.1055/s-0038-1675373. Epub 2018 Nov 2.

PMID:
30388716
15.

The Effect of Blood Loss on Cefazolin Levels in Women Undergoing Cesarean Delivery.

Dotters-Katz SK, Smid MC, Grace MR, Gunatilake RP, Sykes C, Blake K, Boggess KA, Patil AS, Manuck T.

Am J Perinatol. 2019 Jun;36(7):688-694. doi: 10.1055/s-0038-1673654. Epub 2018 Oct 18.

PMID:
30336498
16.

Labor Induction versus Expectant Management in Low-Risk Nulliparous Women.

Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, Hill K, Thom EA, El-Sayed YY, Perez-Delboy A, Rouse DJ, Saade GR, Boggess KA, Chauhan SP, Iams JD, Chien EK, Casey BM, Gibbs RS, Srinivas SK, Swamy GK, Simhan HN, Macones GA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network.

N Engl J Med. 2018 Aug 9;379(6):513-523. doi: 10.1056/NEJMoa1800566.

17.

Practice Variation in Antenatal Steroid Administration for Anticipated Late Preterm Birth: A Physician Survey.

Battarbee AN, Clapp MA, Boggess KA, Kaimal A, Snead C, Schulkin J, Aliaga S.

Am J Perinatol. 2019 Jan;36(2):200-204. doi: 10.1055/s-0038-1667028. Epub 2018 Jul 17.

PMID:
30016819
18.

Institutional Protocols for Vaginal Preparation With Antiseptic Solution and Surgical Site Infection Rate in Women Undergoing Cesarean Delivery During Labor.

La Rosa M, Jauk V, Saade G, Boggess K, Longo S, Clark EAS, Esplin S, Cleary K, Wapner R, Letson K, Owens MY, Blackwell S, Szychowski JM, Andrews WW, Tita AT; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium.

Obstet Gynecol. 2018 Aug;132(2):371-376. doi: 10.1097/AOG.0000000000002745.

19.

Targeted Multiplex Gene Expression Profiling to Measure High-Fat Diet and Metformin Effects on Fetal Gene Expression in a Mouse Model.

Vora NL, Grace MR, Smeester L, Dotters-Katz SK, Fry RC, Bae-Jump V, Boggess K.

Reprod Sci. 2019 May;26(5):683-689. doi: 10.1177/1933719118786453. Epub 2018 Jul 5.

PMID:
29976116
20.

Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S.

Becker-Dreps S, Butler AM, McGrath LJ, Boggess KA, Weber DJ, Li D, Hudgens MG, Layton JB.

Am J Prev Med. 2018 Aug;55(2):159-166. doi: 10.1016/j.amepre.2018.04.013. Epub 2018 Jun 14.

21.

Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy.

Boggess KA, Baker JB, Murtha AP, Peaceman AM, Shah DM, Siegfried SL, Birch R.

AJP Rep. 2018 Apr;8(2):e106-e112. doi: 10.1055/s-0038-1639331. Epub 2018 May 14.

22.

Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice.

Li F, Kakoki M, Smid M, Boggess K, Wilder J, Hiller S, Bounajim C, Parnell SE, Sulik KK, Smithies O, Maeda-Smithies N.

Hypertension. 2018 May;71(5):894-903. doi: 10.1161/HYPERTENSIONAHA.117.10849. Epub 2018 Apr 2.

23.

Risk-Reducing Salpingectomy Versus Standard Tubal Sterilization: Lessons From Offering Women Options for Interval Sterilization.

Zerden ML, Castellano T, Doll KM, Stuart GS, Munoz MC, Boggess KA.

South Med J. 2018 Mar;111(3):173-177. doi: 10.14423/SMJ.0000000000000779.

24.

Use of prophylactic antibiotics in women with previable prelabor rupture of membranes.

Dotters-Katz SK, Myrick O, Smid M, Manuck TA, Boggess KA, Goodnight W.

J Neonatal Perinatal Med. 2017;10(4):431-437. doi: 10.3233/NPM-16165.

PMID:
29286934
25.

A Pilot Quality Improvement Collaborative to Improve Safety Net Dental Access for Pregnant Women and Young Children.

Vander Schaaf EB, Quinonez RB, Cornett AC, Randolph GD, Boggess K, Flower KB.

Matern Child Health J. 2018 Feb;22(2):255-263. doi: 10.1007/s10995-017-2397-6.

PMID:
29168163
26.

Risks and Benefits of Salpingectomy at the Time of Sterilization.

Castellano T, Zerden M, Marsh L, Boggess K.

Obstet Gynecol Surv. 2017 Nov;72(11):663-668. doi: 10.1097/OGX.0000000000000503. Review.

PMID:
29164264
27.

Toxic metals in amniotic fluid and altered gene expression in cell-free fetal RNA.

Smeester L, Martin EM, Cable P, Bodnar W, Boggess K, Vora NL, Fry RC.

Prenat Diagn. 2017 Dec;37(13):1364-1366. doi: 10.1002/pd.5183.

28.

Perioperative Antibiotic Choice in Labored versus Unlabored Cesareans and Risk of Postcesarean Infectious Morbidity.

Hopkins MK, Dotters-Katz S, Boggess K, Heine RP, Smid M.

Am J Perinatol. 2018 Jan;35(2):127-133. doi: 10.1055/s-0037-1606187. Epub 2017 Aug 24.

PMID:
28838006
29.

Maternal Gut Microbiome Biodiversity in Pregnancy.

Smid MC, Ricks NM, Panzer A, Mccoy AN, Azcarate-Peril MA, Keku TO, Boggess KA.

Am J Perinatol. 2018 Jan;35(1):24-30. doi: 10.1055/s-0037-1604412. Epub 2017 Jul 27.

30.

Prenatal Tdap immunization and risk of maternal and newborn adverse events.

Layton JB, Butler AM, Li D, Boggess KA, Weber DJ, McGrath LJ, Becker-Dreps S.

Vaccine. 2017 Jul 24;35(33):4072-4078. doi: 10.1016/j.vaccine.2017.06.071. Epub 2017 Jun 29.

31.

Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges.

Vora NL, Powell B, Brandt A, Strande N, Hardisty E, Gilmore K, Foreman AKM, Wilhelmsen K, Bizon C, Reilly J, Owen P, Powell CM, Skinner D, Rini C, Lyerly AD, Boggess KA, Weck K, Berg JS, Evans JP.

Genet Med. 2017 Nov;19(11):1207-1216. doi: 10.1038/gim.2017.33. Epub 2017 May 18.

32.

Maternal super obesity and risk for intensive care unit admission in the MFMU Cesarean Registry.

Smid MC, Dotters-Katz SK, Vaught AJ, Vladutiu CJ, Boggess KA, Stamilio DM.

Acta Obstet Gynecol Scand. 2017 Aug;96(8):976-983. doi: 10.1111/aogs.13145. Epub 2017 May 27.

PMID:
28382734
33.

Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia.

Mateus J, Newman R, Sibai BM, Li Q, Barton JR, Combs CA, Guzman E, Boggess KA, Gyamfi C, von Dadelszen P, Woelkers D.

AJP Rep. 2017 Jan;7(1):e49-e58. doi: 10.1055/s-0037-1601866.

34.

Predictors of Low Uptake of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Immunization in Privately Insured Women in the United States.

Butler AM, Layton JB, Li D, Hudgens MG, Boggess KA, McGrath LJ, Weber DJ, Becker-Dreps S.

Obstet Gynecol. 2017 Apr;129(4):629-637. doi: 10.1097/AOG.0000000000001927.

35.

Sexual epigenetic dimorphism in the human placenta: implications for susceptibility during the prenatal period.

Martin E, Smeester L, Bommarito PA, Grace MR, Boggess K, Kuban K, Karagas MR, Marsit CJ, O'Shea TM, Fry RC.

Epigenomics. 2017 Mar;9(3):267-278. doi: 10.2217/epi-2016-0132. Epub 2017 Feb 17.

36.

Maternal obesity and major intraoperative complications during cesarean delivery.

Smid MC, Vladutiu CJ, Dotters-Katz SK, Boggess KA, Manuck TA, Stamilio DM.

Am J Obstet Gynecol. 2017 Jun;216(6):614.e1-614.e7. doi: 10.1016/j.ajog.2017.02.011. Epub 2017 Feb 14.

PMID:
28209495
37.

Risk Factors for Postcesarean Maternal Infection in a Trial of Extended-Spectrum Antibiotic Prophylaxis.

Boggess KA, Tita A, Jauk V, Saade G, Longo S, Clark EA, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Blackwell S, Beamon C, Szychowski JM, Andrews W; Cesarean Section Optimal Antibiotic Prophylaxis Trial Consortium.

Obstet Gynecol. 2017 Mar;129(3):481-485. doi: 10.1097/AOG.0000000000001899.

38.

Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.

Tita ATN, Boggess K, Saade G.

N Engl J Med. 2017 Jan 12;376(2):182. doi: 10.1056/NEJMc1614626. No abstract available.

PMID:
28076707
39.

Maternal Morbidity After Previable Prelabor Rupture of Membranes.

Dotters-Katz SK, Panzer A, Grace MR, Smid MC, Keku JA, Vladutiu CJ, Boggess KA, Manuck TA.

Obstet Gynecol. 2017 Jan;129(1):101-106. doi: 10.1097/AOG.0000000000001803.

PMID:
27926655
40.

miRNAs as common regulators of the transforming growth factor (TGF)-β pathway in the preeclamptic placenta and cadmium-treated trophoblasts: Links between the environment, the epigenome and preeclampsia.

Brooks SA, Martin E, Smeester L, Grace MR, Boggess K, Fry RC.

Food Chem Toxicol. 2016 Dec;98(Pt A):50-57. doi: 10.1016/j.fct.2016.06.023. Epub 2016 Jun 29.

41.

Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.

Tita AT, Szychowski JM, Boggess K, Saade G, Longo S, Clark E, Esplin S, Cleary K, Wapner R, Letson K, Owens M, Abramovici A, Ambalavanan N, Cutter G, Andrews W; C/SOAP Trial Consortium.

N Engl J Med. 2016 Sep 29;375(13):1231-41. doi: 10.1056/NEJMoa1602044.

42.

Investigating the Role of Fetal Gene Expression in Preterm Birth.

Vora NL, Smeester L, Boggess K, Fry RC.

Reprod Sci. 2017 Jun;24(6):824-828. doi: 10.1177/1933719116670038. Epub 2016 Sep 27.

43.

First Trimester Maternal Glycated Hemoglobin and Sex Hormone-Binding Globulin Do Not Predict Third Trimester Glucose Intolerance of Pregnancy.

Berggren EK, Boggess KA, Mathew L, Culhane J.

Reprod Sci. 2017 Apr;24(4):613-618. doi: 10.1177/1933719116667230. Epub 2016 Sep 27.

PMID:
27613817
44.

Prophylactic Antibiotics in Twin Pregnancies Complicated by Previable Preterm Premature Rupture of Membranes.

Myrick O, Dotters-Katz S, Grace M, Manuck T, Boggess K, Goodnight W.

AJP Rep. 2016 Jul;6(3):e277-82. doi: 10.1055/s-0036-1587324.

45.

Maternal Super Obesity and Neonatal Morbidity after Term Cesarean Delivery.

Smid MC, Vladutiu CJ, Dotters-Katz SK, Manuck TA, Boggess KA, Stamilio DM.

Am J Perinatol. 2016 Oct;33(12):1198-204. doi: 10.1055/s-0036-1586122. Epub 2016 Jul 27.

PMID:
27464019
46.

Identification of Epigenetic Factor Proteins Expressed in Human Embryonic Stem Cell-Derived Trophoblasts and in Human Placental Trophoblasts.

Sarkar P, Mischler A, Randall SM, Collier TS, Dorman KF, Boggess KA, Muddiman DC, Rao BM.

J Proteome Res. 2016 Aug 5;15(8):2433-44. doi: 10.1021/acs.jproteome.5b01118. Epub 2016 Jul 18.

PMID:
27378238
47.

Birthweight Extremes and Neonatal and Childhood Outcomes after Preterm Premature Rupture of Membranes.

Grace MR, Dotters-Katz S, Varner MW, Boggess K, Manuck TA.

Am J Perinatol. 2016 Oct;33(12):1138-44. doi: 10.1055/s-0036-1584898. Epub 2016 Jul 1.

PMID:
27367280
48.

Center Variation in the Delivery of Indicated Late Preterm Births.

Aliaga S, Zhang J, Long DL, Herring AH, Laughon M, Boggess K, Reddy UM, Grantz KL.

Am J Perinatol. 2016 Aug;33(10):1008-16. doi: 10.1055/s-0036-1582129. Epub 2016 Apr 27.

49.

Management of Pregnant Women with Type 2 Diabetes Mellitus and the Consequences of Fetal Programming in Their Offspring.

Berry DC, Boggess K, Johnson QB.

Curr Diab Rep. 2016 May;16(5):36. doi: 10.1007/s11892-016-0733-7. Review.

PMID:
26983624
50.

Pregnant Women's Infant Oral Health Knowledge and Beliefs: Influence of Having Given Birth and of Having a Child in the Home.

Baker SD, Quiñonez RB, Boggess K, Phillips C.

Matern Child Health J. 2016 Jun;20(6):1288-95. doi: 10.1007/s10995-016-1930-3.

PMID:
26961141

Supplemental Content

Loading ...
Support Center